ENTITY

Lexicon Pharmaceuticals (LXRX US)

Analysis

Health Care • United States

Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches treatments for diabetes and obesity, cardiovascular disease, psychiatric and neurological disorders, cancer, immune system disorders, and ophthalmic disease.

Refresh

Focused

No publications yet

There aren’t any syndicated reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00